Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-000876
Filing Date
2012-01-27
Accepted
2012-01-27 16:37:17
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q calypte_10q-093011.htm 10-Q 706857
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 12194
3 EXHIBIT 32.1 ex32-1.htm EX-32.1 4910
  Complete submission text file 0001437749-12-000876.txt   2939300

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE cbmc-20110930.xml EX-101.INS 468206
5 XBRL TAXONOMY EXTENSION SCHEMA cbmc-20110930.xsd EX-101.SCH 15719
6 XBRL TAXONOMY EXTENSION CALCULATION cbmc-20110930_cal.xml EX-101.CAL 26585
7 XBRL TAXONOMY EXTENSION DEFINITION cbmc-20110930_def.xml EX-101.DEF 77615
8 XBRL TAXONOMY EXTENSION LABELS cbmc-20110930_lab.xml EX-101.LAB 109039
9 XBRL TAXONOMY EXTENSION PRESENTATION cbmc-20110930_pre.xml EX-101.PRE 88932
Mailing Address 5000 HOPYARD ROAD, SUITE 480 PLEASANTON CA 94588
Business Address 5000 HOPYARD ROAD, SUITE 480 PLEASANTON CA 94588 9257307200
CALYPTE BIOMEDICAL CORP (Filer) CIK: 0000899426 (see all company filings)

EIN.: 061226727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32280 | Film No.: 12552269
SIC: 3826 Laboratory Analytical Instruments